These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 38960460)
21. Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease. Lazarus B; Chen Y; Wilson FP; Sang Y; Chang AR; Coresh J; Grams ME JAMA Intern Med; 2016 Feb; 176(2):238-46. PubMed ID: 26752337 [TBL] [Abstract][Full Text] [Related]
22. Proton pump inhibitor use and risk of pneumonia: a self-controlled case series study. Maret-Ouda J; Panula J; Santoni G; Xie S; Lagergren J J Gastroenterol; 2023 Aug; 58(8):734-740. PubMed ID: 37314495 [TBL] [Abstract][Full Text] [Related]
23. Beyond uncertainty: Negative findings for the association between the use of proton pump inhibitors and risk of dementia. Park SK; Nam JH; Lee H; Chung H; Lee EK; Shin JY J Gastroenterol Hepatol; 2019 Dec; 34(12):2135-2143. PubMed ID: 31145825 [TBL] [Abstract][Full Text] [Related]
24. Association Between Proton Pump Inhibitor Use and Biliary Tract Cancer Risk: A Swedish Population-Based Cohort Study. Kamal H; Sadr-Azodi O; Engstrand L; Brusselaers N Hepatology; 2021 Oct; 74(4):2021-2031. PubMed ID: 34018229 [TBL] [Abstract][Full Text] [Related]
25. Association Between Proton Pump Inhibitor Use and Risk of Fracture in Children. Wang YH; Wintzell V; Ludvigsson JF; Svanström H; Pasternak B JAMA Pediatr; 2020 Jun; 174(6):543-551. PubMed ID: 32176276 [TBL] [Abstract][Full Text] [Related]
26. Long-term continuous use of proton-pump inhibitors is associated with renal function decline in patients without acute kidney injury. Hatakeyama Y; Horino T; Matsumoto T; Terada Y; Okuhara Y Clin Exp Nephrol; 2021 Oct; 25(10):1087-1092. PubMed ID: 34089392 [TBL] [Abstract][Full Text] [Related]
29. Proton Pump Inhibitors, Histamine-2 Receptor Antagonists, and Hip Fracture Risk among Patients on Hemodialysis. Vangala C; Niu J; Lenihan CR; Mitch WE; Navaneethan SD; Winkelmayer WC Clin J Am Soc Nephrol; 2018 Oct; 13(10):1534-1541. PubMed ID: 30262672 [TBL] [Abstract][Full Text] [Related]
30. Long-term use of proton pump inhibitors, dose-response relationship and associated risk of ischemic stroke and myocardial infarction. Sehested TSG; Gerds TA; Fosbøl EL; Hansen PW; Charlot MG; Carlson N; Hlatky MA; Torp-Pedersen C; Gislason GH J Intern Med; 2018 Mar; 283(3):268-281. PubMed ID: 29024109 [TBL] [Abstract][Full Text] [Related]
31. Comparative analysis of the risk of osteoporotic fractures with proton pump inhibitor use and histamine-2 receptor antagonist therapy in elderly women: A nationwide population-based nested case-control study. Park JH; Song YM; Jung JH; Han K Bone; 2020 Jun; 135():115306. PubMed ID: 32126312 [TBL] [Abstract][Full Text] [Related]
32. Association between proton pump inhibitors use and risk of hip fracture: A general population-based cohort study. Wei J; Chan AT; Zeng C; Bai X; Lu N; Lei G; Zhang Y Bone; 2020 Oct; 139():115502. PubMed ID: 32593677 [TBL] [Abstract][Full Text] [Related]
33. Proton pump inhibitors and survival in patients with colorectal cancer: a Swedish population-based cohort study. Wang X; Liu Q; Halfdanarson ÓÖ; Zoega H; Sadr-Azodi O; Engstrand L; Fall K; Brusselaers N Br J Cancer; 2021 Sep; 125(6):893-900. PubMed ID: 34253872 [TBL] [Abstract][Full Text] [Related]
34. Proton Pump Inhibitor Use and Obesity-Associated Cancer in the Women's Health Initiative. Ballinger TJ; Djuric Z; Sardesai S; Hovey KM; Andrews CA; Brasky TM; Zhang JT; Rohan TE; Saquib N; Shadyab AH; Simon M; Wactawski-Wende J; Wallace R; Kato I Nutr Cancer; 2023; 75(1):265-275. PubMed ID: 35968582 [TBL] [Abstract][Full Text] [Related]
35. No Increase in Risk of Acute Myocardial Infarction in Privately Insured Adults Prescribed Proton Pump Inhibitors vs Histamine-2 Receptor Antagonists (2002-2014). Landi SN; Sandler RS; Pate V; Lund JL Gastroenterology; 2018 Mar; 154(4):861-873.e6. PubMed ID: 29122546 [TBL] [Abstract][Full Text] [Related]
36. Clinical Outcomes of Acid Suppressive Therapy Use in Hematology/Oncology Patients at an Academic Medical Center. McCaleb RV; Gandhi AS; Clark SM; Clemmons AB Ann Pharmacother; 2016 Jul; 50(7):541-7. PubMed ID: 27091869 [TBL] [Abstract][Full Text] [Related]
37. Proton pump inhibitors are associated with a high rate of serious infections in veterans with decompensated cirrhosis. Bajaj JS; Ratliff SM; Heuman DM; Lapane KL Aliment Pharmacol Ther; 2012 Nov; 36(9):866-74. PubMed ID: 22966967 [TBL] [Abstract][Full Text] [Related]
38. Safety of Concomitant Metformin and Proton Pump Inhibitor Use: A Population Retrospective Cohort Study. Chen CB; Lin M; Eurich DT; Johnson JA Clin Ther; 2016 Jun; 38(6):1392-1400. PubMed ID: 27061884 [TBL] [Abstract][Full Text] [Related]
39. Choice of Acid Suppressant Therapy and Long-Term Graft Outcomes After Kidney Transplantation. January SE; Progar K; Nesselhauf NM; Hagopian JC; Malone AF Pharmacotherapy; 2020 Nov; 40(11):1082-1088. PubMed ID: 33037663 [TBL] [Abstract][Full Text] [Related]
40. Acid suppressants use and the risk of dementia: A population-based propensity score-matched cohort study. Wu CL; Lei WY; Wang JS; Lin CE; Chen CL; Wen SH PLoS One; 2020; 15(11):e0242975. PubMed ID: 33253311 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]